Cite

HARVARD Citation

    Vo, A. et al. (n.d.). CLAZAKIZUMAB® (ANTI-IL-6) FOR DESENSITIZATION OF HIGHLY-HLA SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT (NCT03380962). Transplantation. 104 (3), p. . [Online]. 
  
Back to record